Form 4: Shuttle Pharmaceuticals Holdings Officer Mira Jung Reports Stock Disposal

Mira Jung, Chief Scientific Officer of Shuttle Pharmaceuticals Holdings, reports the disposal of 598 shares of Class A Common Stock on May 1, 2024, at a price of $11.28 per share.

Summary

• On October 9, 2024, Mira Jung, the Chief Scientific Officer of Shuttle Pharmaceuticals Holdings, filed a Form 4.
• The form reports a transaction that occurred on May 1, 2024, where Ms. Jung disposed of 598 shares of Class A Common Stock at a price of $11.28 per share.
• This disposal was due to the vesting of restricted stock units (RSUs) granted on May 1, 2023.
• Following the reported transaction, Ms. Jung beneficially owns 135,715 shares, consisting of 134,522 shares of common stock and 1,193 RSUs which remain subject to vesting.
• All share and RSU numbers reflect a 1-for-8 reverse stock split effected by the issuer on August 13, 2024.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, so the sentiment is neutral. It simply reports a transaction.

Industry Context

Form 4 filings are a routine part of regulatory compliance for corporate insiders, providing transparency into their transactions in the company's stock.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it reflects an insider's stock activity due to vesting RSUs.

Key Dates

Keywords

Form 4, insider trading, Shuttle Pharmaceuticals Holdings, Mira Jung, stock disposal, RSUs, reverse stock split, beneficial ownership